Skip to content
OpenCapital
Get started

Aptevo Therapeutics APVO Q4 2024 Annual earnings

Reported March 4, 2025 · Before market open

EPS-$82.37Miss by $74.62
EPS estimate-$7.75

Next report

Aug 10, 2026 (In 1 week)
EPS estimate-$6.02

Versus estimates

Diluted EPS

Q1 2026-$6.41Miss by $0.81Q4 2025$1,684.47Beat by $1,692.56Q3 2025-$40.11Miss by $2.52Q2 2025-$151.08Miss by $150.63Q1 2025-$1,579.14Miss by $64.75
Q4 2024-$82.37Miss by $74.62

Ask the moment Aptevo Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Aptevo Therapeutics report Q4 2024 earnings?
Aptevo Therapeutics (APVO) reported Q4 2024 earnings on March 4, 2025 before market open.
What were Aptevo Therapeutics's Q4 2024 revenue and EPS?
Aptevo Therapeutics reported eps of $-82.37 for Q4 2024.
Did Aptevo Therapeutics beat estimates in Q4 2024?
EPS missed the consensus estimate of $-7.75 by $74.62.
Where can I find Aptevo Therapeutics's Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-020467) directly on SEC EDGAR. The filing index links above go to sec.gov.